Massachusetts Health Care Company Pleads Guilty to Purchasing, Using Botox Not Approved for Use in U.S.

Posted By Madilyn Moeller, Friday, April 28, 2023

Syringe and vials

A Massachusetts health care company has pleaded guilty and agreed to pay millions after officials said it purposefully bought and used Botox that was only labeled for sale in foreign countries.

The Waltham-based Greater Boston Behavioral Health must now pay more than $2.5 million in fines and forfeiture.

“Greater Boston Behavioral Health disregarded laws designed to protect patient safety,” U.S. Attorney Rachael Rollins said in a statement. “The U.S. Attorney’s Office is committed to protecting patients and the integrity of federal health care programs, and we will continue to use our criminal authority to ensure that health care providers play by the rules that protect the public and ensure quality of care.”

Read more at >>